Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02786810 · ClinicalTrials.gov registry record · Phase 2
Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy
A Phase 2 study, sponsored by University of Tennessee.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT02786810: Completed Phase 2 study, sponsored by University of Tennessee.
NCT02786810 is a Phase 2 study that has completed, run by University of Tennessee. The registered enrollment target is 10 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02786810, a Phase 2 study, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The study will be evaluating the efficacy and safety of a contrast drug in pediatric renal ultrasound.
Primary Outcome
The study will evaluate the contrast agent's ability to enable the ultrasound to produce adequate images of the kidneys as compared to the subject's previous renal imaging. This outcome will be measured in percentage of scars visualized by other imaging methods that were detected by using the contrast agent.
Interventions
- DRUG Sulfur hexafluoride type-a lipid microspheres
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-03 |
| Est. Completion | 2016-11 |
| Phase | Phase 2 |
What the finished NCT02786810 record still lists
NCT02786810 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Sulfur hexafluoride type-a lipid microspheres is the first listed.
NCT02786810 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02786810 about?
NCT02786810 is a clinical study titled "Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy". The study will be evaluating the efficacy and safety of a contrast drug in pediatric renal ultrasound.
What is the current status of trial NCT02786810?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2016-03. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02786810?
The interventions under investigation include: Sulfur hexafluoride type-a lipid microspheres (DRUG).
Who is sponsoring clinical trial NCT02786810?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02786810's enrollment target sits among peer trials
10 1968th of 2000 higher than 12 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia